Revised forecast
Fiscal year ending June 2026 · Full yearPrevious forecast published 14 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Although revenue recognition in the Mogecheck business was deferred as billing shifted from referral-based fees to transaction-based fees, procurement and sales in the real estate trading model of the INVASE business remained strong. Profit was supported by controlled advertising expenses, improved customer acquisition efficiency resulting from increased media exposure, the move into profitability through upgraded and more efficient sales activities, a lower tax burden resulting from a reduction in capital, and the recognition of deferred tax assets.
| Item | Details |
|---|---|
| Net Sales | ¥8,092 million → ¥8,317 million（+2.8%） |
| Operating profit | ¥200 million → ¥222 million（+11.1%） |
| Ordinary income | ¥191 million → ¥215 million（+12.7%） |
| Profit attributable to owners of the parent | ¥150 million → ¥308 million（+104.5%） |
| Net income per share | 15.64 yen and sen → 31.99 yen and sen |
| Fiscal Period Covered | Fiscal year ending June 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 14 May 2026 |
| Previous-period results | Fiscal year ended June 2025, consolidated results: revenue ¥2,918 million, operating profit ¥197 million, ordinary profit ¥198 million, net income attributable to owners of the parent ¥160 million, earnings per share ¥17.64 |
| Reason for the revision | Although revenue recognition in the Mogecheck business was deferred as billing shifted from referral-based fees to transaction-based fees, procurement and sales in the real estate trading model of the INVASE business remained strong. Profit was supported by controlled advertising expenses, improved customer acquisition efficiency resulting from increased media exposure, the move into profitability through upgraded and more efficient sales activities, a lower tax burden resulting from a reduction in capital, and the recognition of deferred tax assets. |
| Consolidated / non-consolidated | Consolidated and standalone |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Consolidated revenue increased because procurement and sales in the real estate trading model of the INVASE business remained strong, despite revenue recognition being deferred in the Mogecheck business as billing shifted from referral-based fees to transaction-based fees. Operating profit and ordinary profit increased because advertising expenses were controlled in the Mogecheck business, customer acquisition efficiency improved through increased media exposure, and the INVASE business became profitable as sales activities were upgraded and made more efficient. Net income increased due to a lower tax burden resulting from a reduction in capital and the recognition of deferred tax assets, which resulted in income taxes adjustments being recorded as a gain.